|
Alzheimer Disease
Citations 181-190 of 489 total displayed.
|
Past content
(since Jan 1998):
|
- Original Contributions
Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study
- Ara S. Khachaturian; Peter P. Zandi; Constantine G. Lyketsos; Kathleen M. Hayden; Ingmar Skoog; Maria C. Norton; JoAnn T. Tschanz; Lawrence S. Mayer; Kathleen A. Welsh-Bohmer; John C. S. Breitner; for the Cache County Study Group
Arch Neurol 63.5.noc60013.
[Abstract]
[Full text]
[]
- Original Contributions
Lewy Body Pathology in Familial Alzheimer Disease: Evidence for Disease- and Mutation-Specific Pathologic Phenotype
- James B. Leverenz; Mark A. Fishel; Elaine R. Peskind; Thomas J. Montine; David Nochlin; Ellen Steinbart; Murray A. Raskind; Gerard D. Schellenberg; Thomas D. Bird; Debby Tsuang
Arch Neurol 2006; 63: 370-376.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Magnetoencephalographic Parietal  Dipole Density in Mild Cognitive Impairment: Preliminary Results of a Method to Estimate the Risk of Developing Alzheimer Disease
- Alberto Fernández; Agustín Turrero; Pilar Zuluaga; Pedro Gil; Fernando Maestú; Pablo Campo; Tomás Ortiz
Arch Neurol 2006; 63: 427-430.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Association of Apolipoprotein E Genotype and Alzheimer Disease in African Americans
- Jill R. Murrell; Brandon Price; Kathleen A. Lane; Olusegun Baiyewu; Oye Gureje; Adesola Ogunniyi; Frederick W. Unverzagt; Valerie Smith-Gamble; Sujuan Gao; Hugh C. Hendrie; Kathleen S. Hall
Arch Neurol 2006; 63: 431-434.
[Abstract]
[Full text]
[PDF]
- Clinical Trials
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
- Po H. Lu; Donna A. Masterman; Ruth Mulnard; Carl Cotman; Bruce Miller; Kristine Yaffe; Erin Reback; Verna Porter; Ronald Swerdloff; Jeffrey L. Cummings
Arch Neurol 2006; 63: 177-185.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Relation of Quantitative Indexes of Concurrent  -Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease
- Roee Holtzer; Michael C. Irizarry; Jody Sanders; Bradley T. Hyman; Domonick J. Wegesin; Aliza Riba; Jason Brandt; Marilyn Albert; Yaakov Stern
Arch Neurol 2006; 63: 226-230.
[Abstract]
[Full text]
[PDF]
- Editorials
Mild Cognitive Impairment Is Early-Stage Alzheimer Disease: Time to Revise Diagnostic Criteria
- John C. Morris
Arch Neurol 2006; 63: 15-16.
[Extract]
[Full text]
[PDF]
- Editorials
What We Can Learn From Open-Label Extensions of Randomized Clinical Trials
- Jeffrey L. Cummings
Arch Neurol 2006; 63: 18-19.
[Extract]
[Full text]
[PDF]
- Original Contributions
Neuropathologic Substrate of Mild Cognitive Impairment
- William R. Markesbery; Frederick A. Schmitt; Richard J. Kryscio; Daron G. Davis; Charles D. Smith; David R. Wekstein
Arch Neurol 2006; 63: 38-46.
[Abstract]
[Full text]
[PDF]
- Original Contributions
A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
- Barry Reisberg; Rachelle Doody; Albrecht Stöffler; Frederick Schmitt; Steven Ferris; Hans Jörg Möbius
Arch Neurol 2006; 63: 49-54.
[Abstract]
[Full text]
[PDF]
|
|
